Using cBio Cancer Genomics Portal (cBioPortal) databases, we also found that mutation of TET2 was frequent in cancers, such as uterine cancer, acute myeloid leukemia, and melanoma (Supplementary Fig. S6A). This evidence concerns the gene TET2 and cancer.